<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711434955</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711434955</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>El-Dayem</surname>
<given-names>Samiha M Abd</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711434955"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fouda</surname>
<given-names>Fatma M</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711434955"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ali</surname>
<given-names>Elham H A</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711434955"/>
<xref ref-type="corresp" rid="corresp1-0748233711434955"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Motelp</surname>
<given-names>Bosy A Abd El</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711434955"/>
</contrib>
</contrib-group>
<aff id="aff1-0748233711434955">Department of Zoology, Faculty of Women’s for Arts, Science and Education, Ain Shams University, Egypt</aff>
<author-notes>
<corresp id="corresp1-0748233711434955">Elham H A Ali, Department of Zoology, Faculty of Women’s for Arts, Science and Education, Ain Shams University, Cairo, Egypt. Email: <email>elhamhassan2006@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>29</volume>
<issue>5</issue>
<fpage>404</fpage>
<lpage>417</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The study aimed to investigate the antitumor effect of tetrodotoxin (TTX) and/or doxorubicin (DOX) on Ehrlich ascites carcinoma (EAC)-bearing mice through the investigated biochemical parameters. TTX and/or DOX with or without <italic>N</italic>-acetylcystiene were administrated after 10 days into EAC-female mice for a period of 2 weeks in six equal doses. Treatment with TTX or DOX caused a significant decrease in the mean tumor weight and an increase in the cumulative mean survival time when compared with EAC group. All the treatments reduced the elevated liver tumor markers and increased liver antioxidant enzymes under investigation in comparison with EAC. Hepatic cells, suffered severely from degeneration and karriolysis in EAC group, revealed some improvement as appearance of healthy hepatocytes by TTX treatment. The present results suggested that TTX had a more powerful inhibitor effect on EAC growth than DOX and TTX plus DOX treatments reflected by antitumor biochemical and histological studies.</p>
</abstract>
<kwd-group>
<kwd>Mice</kwd>
<kwd>tetrodotoxin</kwd>
<kwd>doxorubicin</kwd>
<kwd>Ehrlich ascites carcinoma</kwd>
<kwd>antitumor study</kwd>
<kwd>apoptosis</kwd>
<kwd>liver histology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711434955">
<title>Introduction</title>
<p>Cancer continues to represent the largest cause of mortality and the major public health problem in most parts of the world and claims over 6 million lives every year (<xref ref-type="bibr" rid="bibr42-0748233711434955">Jemal et al., 2008</xref>). The deadliest part of the cancer process, metastasis, appears to rely on the help from macrophages, potent immune system cells, that usually defend vigorously against disease. Metastatic tumor growth is inhibited if these unusual macrophages are killed. In addition, metastatic disease is the major cause of cancer mortality (<xref ref-type="bibr" rid="bibr58-0748233711434955">Pollard, 2009</xref>).</p>
<p>Doxorubicin HCl (DOX) is a cytotoxic anthracycline antibiotic isolated from <italic>Streptomyces peucetius</italic> var. caesius (<xref ref-type="bibr" rid="bibr4-0748233711434955">Arcamone et al., 1969a</xref>, <xref ref-type="bibr" rid="bibr5-0748233711434955">1969b</xref>). It possesses a broad spectrum of antitumor activity, exhibits a wide activity against leukemias and breast, lung, thyroid and ovarian carcinomas as well as against Hodgkin’s and non-Hodgkin’s lymphomas (<xref ref-type="bibr" rid="bibr50-0748233711434955">Longhu et al., 2006</xref>). But its clinical use is limited by its adverse side effects: irreversible degenerative cardiomyopathy and congestive heart failure (<xref ref-type="bibr" rid="bibr3-0748233711434955">Aleisa et al., 2007</xref>; <xref ref-type="bibr" rid="bibr49-0748233711434955">Lee et al., 2009</xref>).</p>
<p>Tetrodotoxin (TTX) is a naturally occurring potent toxin and a highly selective sodium channel blocker (<xref ref-type="bibr" rid="bibr24-0748233711434955">Fouda, 2005</xref>). The toxin name is ascribed to the puffer fish (Tetraodontidae), the most commonly available source of TTX (<xref ref-type="bibr" rid="bibr39-0748233711434955">Hwang and Noguchi, 2007</xref>). <italic>N</italic>-acetylcysteine (NAC), an aminothiol, is a sulphydryl group donor and precursor of glutathione (GSH) (<xref ref-type="bibr" rid="bibr78-0748233711434955">Zandwijk, 2004</xref>). It is considered as one of the most promising cancer chemopreventive agents (<xref ref-type="bibr" rid="bibr64-0748233711434955">Shi et al., 2009</xref>).</p>
<p>It is well recognized that apoptosis is a mode of cell death used by multicellular organisms to eradicate cells in diverse physiological and pathological settings (<xref ref-type="bibr" rid="bibr38-0748233711434955">Huo et al., 2004</xref>). One of the hallmarks of apoptosis is the cleavage of chromosomal DNA into nucleosomal units. The degradation of DNA in the nuclei of apoptotic cells is accomplished in a number of ways following the activation of caspases. DNA topoisomerase II is a nuclear enzyme essential for DNA replication and repair. Caspases can inactivate this enzyme leading to DNA damage (<xref ref-type="bibr" rid="bibr35-0748233711434955">Herrera-Mendez et al., 2006</xref>). Tumor necrosis factor (TNF) is an extraordinarily pleiotropic cytokine with a central role in immune homeostasis, inflammation, and host defense (<xref ref-type="bibr" rid="bibr73-0748233711434955">Warren et al., 2009</xref>). Dependent on the cellular context, it can induce such diverse effects as apoptosis, necrosis, angiogenesis, immune cell activation, differentiation, and cell migration. These processes are of great relevance in tumor immune surveillance and also play crucial roles in tumor development and tumor progression (<xref ref-type="bibr" rid="bibr71-0748233711434955">Wajant, 2009</xref>).</p>
<p>So, the present work was designed to investigate the antitumor activity of TTX and/or DOX with antioxidants NAC on Ehrlich ascites carcinoma (EAC) mice and to test whether the treatment with both natural toxin TTX and synthetic agent DOX together has an effect on the antitumor property of each.</p>
</sec>
<sec id="section2-0748233711434955" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0748233711434955">
<title>Influence of sex on the growth of the Ehrlich ascites tumor</title>
<p>The present study was conducted to investigate the influence of sex on the growth of the Ehrlich ascites tumor in the peritoneal cavity and between thighs for the formation of liquid and solid tumors in 30 male and 30 female mice weighing 22–25 g. The results revealed that significantly less growth occurred in male mice than in female mice inoculated with tumor cells. The solid tumor did not grow up in male mice and formed scars and infiltration of pus cells. This may be due to the Ehrlich cells that were discovered in the female breast (breast cancer), and hence, the female hormones may affected its growth. This is consistent with <xref ref-type="bibr" rid="bibr70-0748233711434955">Vincent and Nicholls (1967</xref>). They found that EAC cells show greater initial growth and higher total cell count in female mice than male mice. So, the present study used the female mice.</p>
</sec>
<sec id="section4-0748233711434955">
<title>Tumor cell line</title>
<p>The initial inoculation of EAC cells was kindly provided by the National Cancer Institute (Cairo University, Egypt). EAC cells were thereafter propagating in our laboratory by weekly intraperitoneal (IP) injection of 2.5 × 10<sup>6</sup> cells per mouse, which was carried out according to the method recommended by the Egyptian National Cancer Institute, Cairo University. Cells were counted before injection using the bright line hemocytometer and dilutions were made by physiological saline, and the desired number of cells was injected in a volume of 0.5 ml per mouse.</p>
</sec>
<sec id="section5-0748233711434955">
<title>Animals</title>
<p>Adult female Swiss albino mice weighing 22–25 g were obtained from the animal house of Egyptian National Cancer Institute, Cairo University. The local committee approved the design of the experiments, and the protocol conforms to the guidelines of the National Institutes of Health. The animals were maintained on a standard pellet diet and tap water <italic>ad libitum</italic>.</p>
</sec>
<sec id="section6-0748233711434955">
<title>Chemicals</title>
<sec id="section7-0748233711434955">
<title>Doxorubicin</title>
<p>DOX was manufactured by Pharmacia Italia SPA.</p>
<sec id="section8-0748233711434955">
<title>Tetrodotoxin</title>
<p>TTX was obtained from the skin of the puffer fish or fugu (<italic>Arothron diadematus</italic>) according to the method of <xref ref-type="bibr" rid="bibr46-0748233711434955">Kawabata (1978</xref>). The skins of two masked puffer fish (<italic>A. diadematus</italic>) were prepared using acidified methanol extract solution. The extract was then boiled for 10 min, cooled, centrifuged at 1000 r/min for 3–5 min and the supernatant containing the TTX was stored at −4°c until used.</p>
</sec>
<sec id="section9-0748233711434955">
<title>Assessment of toxicity (mouse units)</title>
<p>The toxicity of TTX extracted from the fish skin was determined in mouse units. The mouse unit is defined as the amount of toxin required to kill a mouse weighing 20 g within 30 min (<xref ref-type="bibr" rid="bibr24-0748233711434955">Fouda, 2005</xref>; <xref ref-type="bibr" rid="bibr46-0748233711434955">Kawabata, 1978</xref>).</p>
</sec>
<sec id="section10-0748233711434955">
<title>N-acetyl cysteine</title>
<p>It is obtained from Sigma-Aldrich Company (USA). </p>
<p>The tested compounds were administered at a dosage of 15 mg/kg body weight (bwt) of DOX (<xref ref-type="bibr" rid="bibr68-0748233711434955">Timao and Singal, 2000</xref>); 1/20 lethal dose (LD) of TTX (<xref ref-type="bibr" rid="bibr24-0748233711434955">Fouda, 2005</xref>) and 50 mg/kg bwt of NAC (<xref ref-type="bibr" rid="bibr43-0748233711434955">Kalaiselvi et al., 2005</xref>).</p>
</sec>
</sec>
</sec>
<sec id="section11-0748233711434955">
<title>Experimental protocol</title>
<sec id="section12-0748233711434955">
<title>Animals were assigned into eight groups</title>
<p>The first group received IP injection of physiological saline and served as a control group. The groups 2 to 8 were injected subcutaneously with 2.5 × 10<sup>6</sup> EAC/ml in the back between the thighs of each animal to form a solid tumor (<xref ref-type="bibr" rid="bibr20-0748233711434955">Fahim et al., 1997</xref>). Groups 3–8 received IP injection of DOX (G3; 15 mg/kg); TTX (G4; 1/20 LD); TTX + DOX (G5; injected TTX half hour before DOX administration); NAC + DOX (G6; 50 mg/kg NAC 1 h before DOX administration); NAC + TTX (G7; TTX (1/20 LD) and NAC 1 h before TTX administration) and NAC + TTX + DOX (G8; injected with doses of NAC 1 h before TTX and TTX half hour before DOX), respectively. Six injections of equal dosage were given on a daily basis for a period of 2 weeks. All the groups were killed on the 24th day of experiment for sampling and examination of biochemical and histological parameters (10 days after inoculating the EAC cells (when the tumor becomes papale) + 14 days of treatment).</p>
</sec>
</sec>
<sec id="section13-0748233711434955">
<title>Antitumor studies</title>
<p>The antitumor activities of DOX, TTX and/or NAC were assessed on 350 mice used to determine the mortality rate and to calculate the mean tumor weight (MTW) until the end of study. The latter were classified into seven equal-sized groups (groups 2–8), each group containing 50 mice. Ten days after inoculating the EAC cells (when the tumor becomes papale), the animals in group 2 received no treatment and served as the tumor control group. The animals in groups 3–8 were injected as mentioned before. Then, these groups were left untreated until the end of the experiment. The weight of the solid tumor was determined by killing three animals every week and by taking the MTW. The cumulative mean survival time, the increase in life span (ILS, %) and the tumor growth inhibition ratio (T/C, %) were recorded as given by <xref ref-type="bibr" rid="bibr21-0748233711434955">Fahim et al. (2003</xref>). Mean survival time is the days at which the animals were alive. ILS, % = mean survival time of test/mean survival time of control × 100. Tumor inhibition ratio (T/C, %) = MTW of control − MTW of test/MTW of control × 100.</p>
</sec>
<sec id="section15-0748233711434955">
<title>Biochemical measurement</title>
<p>At the end of the 24 days of experimental period, six mice were fasted overnight, anesthetized under diethyl ether (Sigma Co., USA) and the blood was collected by cardiac puncture into dry clean heparinized tubes. The blood tubes were left for 30 min and then centrifuged at 3000 r/min for 30 min. After centrifugation, the plasma was separated at once, divided into aliquots and stored at −70°C until used in the biochemical analysis. Plasma glucose concentration was determined according to the method of <xref ref-type="bibr" rid="bibr77-0748233711434955">Young (2001)</xref> using kits purchased from SPINREACT Company (Egypt). Glucose-6-phosphate dehydrogenase (G6PHD) was measured according to the method of <xref ref-type="bibr" rid="bibr47-0748233711434955">Kornberg et al. (1955</xref>) using kits purchased from Bio-Diagnostic Company.</p>
<p>Liver was excised immediately from the animals (mice) after dissection and carefully washed with cold saline, dried and weighed. Fresh liver sample, usually 0.5 g, was homogenized in 5 ml of 0.9% NaCl saline and used for determination of the following: liver γ-glutamyltransferase (GGT) was determined by the method of <xref ref-type="bibr" rid="bibr66-0748233711434955">Szasz and Persjn (1974)</xref> using a commercial kit purchased from Egyptian company for Biotechnology (Egypt). Hepatic TNF-α was determined using a corresponding enzyme-linked immunosorbent assay kit purchased from Bender Med-Systems Company (Europe). Activity of Caspase-3 was determined by the method of Kamada<xref ref-type="bibr" rid="bibr45-0748233711434955"> et al. (1998</xref>) using the Caspase-3 Assay Kit, colorimetry (Product Code CASP-3-C) from Sigma-Aldrich Company. Total protein in liver tissue was determined by the method of Young (2001). Malondialdehyde (MDA), as one of the main end products of lipid peroxidation, is currently estimated by the thiobarbituric acid test according to the method of <xref ref-type="bibr" rid="bibr57-0748233711434955">Ohkawa et al. (1979</xref>) using commercial kit purchased from Bio-Diagnostic Company (Egypt). Liver GSH content was determined according to the method of Beutler<xref ref-type="bibr" rid="bibr8-0748233711434955"> et al. (1963</xref>). Activity of glutathione <italic>S</italic>-transferase (GST) was determined by the method of Habig<xref ref-type="bibr" rid="bibr34-0748233711434955"> et al. (1974</xref>). Activity of liver glutathione peroxidase (GPX) was measured by the decrease in reduced nicotinamide adenine dinucleotide phosphate according to the method of Gross<xref ref-type="bibr" rid="bibr31-0748233711434955"> et al. (1967</xref>). Activity of superoxide dismutase (SOD) was carried out by monitoring the auto-oxidation of pyrogallol, according to the method of <xref ref-type="bibr" rid="bibr52-0748233711434955">Minami and Yoshikawa (1979</xref>). All chemicals were purchased from Sigma Co. (USA). </p>
</sec>
<sec id="section17-0748233711434955">
<title>Histological examination</title>
<p>For histopathological study, during dissection, parts from the livers of the previous animals from each group were separated and stored in 10% buffered formalin. They were later sectioned (5S thick) using a microtome, dehydrated in graded alcohol, embedded in paraffin section and stained with hematoxylin and eosin (<xref ref-type="bibr" rid="bibr18-0748233711434955">Drury and Wallington, 1980</xref>). Then they were viewed using a Lecia-DM2500 (Germany) microscope.</p>
</sec>
<sec id="section19-0748233711434955">
<title>Statistical analysis</title>
<p>Reported values represent means ± standard error. Statistical analysis was evaluated by one-way analysis of variance. Once a significant <italic>F</italic> test was obtained, least significant difference (LSD) comparisons were performed to assess the significance of differences among various treatment groups. Statistical Processor System Support “SPSS” for Windows software, release 12.0 (SPSS, Chicago, Illinois, USA), was used.</p>
</sec>
</sec>
<sec id="section20-0748233711434955">
<title>Results</title>
<sec id="section21-0748233711434955">
<title>Antitumor studies</title>
<p><xref ref-type="table" rid="table1-0748233711434955">Table 1</xref> reveals that the treatment of tumor-bearing animals with TTX (G4) and NAC + TTX (G7) induced an increase in the life span (ILS, %), which amounted to 153.33 and 160, respectively, compared with tumor-bearing controls (G2). The DOX-treated (G3) and NAC + DOX-treated (G6) groups showed an increase in the life span (ILS, %), which amounted to 140 in both the groups, while the life span is recorded as 58.88 and 80 in TTX + DOX-treated (G5) and TTX + NAC + DOX-treated (G8) groups, respectively, when compared with tumor-bearing controls. On day 60, at the time when all tumor-bearing control animals were dead, the MTW was recorded as 9.50 ± 0.17. The mean weight decreased significantly in G4- and G7-treated groups to reach 4.90 ± 0.14 and 4.90 ± 0.06, respectively. While in G3- and G6-treated groups, MTW recording decreased significantly 3.66 ± 0.14 and 5.21 ± 0.04, respectively, in relation with tumor-bearing control. On the other hand, on day 48, at the time when all animals of G8 were dead, the MTW recorded 2.61 ± 0.06, while it reached to 0.67 ± 0.03 in G5 at 30 days with the elevation of the T/C (%).</p>
<table-wrap id="table1-0748233711434955" position="float">
<label>Table 1.</label>
<caption>
<p>Antitumor activities of TTX, DOX and/or NAC on solid Ehrlich ascites carcinoma compared with tumor-bearing controls.</p>
</caption>
<graphic alternate-form-of="table1-0748233711434955" xlink:href="10.1177_0748233711434955-table1.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">PT1 (days)</th>
<th colspan="2">(G2) T</th>
<th colspan="2">(G3) T + DOX</th>
<th colspan="2">(G4) T + TTX</th>
<th colspan="2">(G5) T + TTX + DOX</th>
<th colspan="2">(G6) T + NAC + DOX</th>
<th colspan="2">(G7) T + NAC + TTX</th>
<th colspan="2">(G8) T + NAC + TTX + DOX</th>
</tr>
<tr>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
<th>M</th>
<th>MTW ± SE</th>
</tr>
</thead>
<tbody>
<tr>
<td>10</td>
<td>0/8</td>
<td>1.13 ± 0.04</td>
<td>0/8</td>
<td>1.10 ± 0.06</td>
<td>0/8</td>
<td>1.16 ± 0.09</td>
<td>0/8</td>
<td>1.34 ± 0.14</td>
<td>0/8</td>
<td>1.46 ± 0.1<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>1.52 ± 0.06<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>1.22 ± 0.04<sup>f</sup>
</td>
</tr>
<tr>
<td>17</td>
<td>0/8</td>
<td>2.51 ± 0.04</td>
<td>0/8</td>
<td>2.36 ± 0.12</td>
<td>0/8</td>
<td>1.84 ± 0.28<sup>a</sup>
</td>
<td>2/8</td>
<td>1.33 ± 0.04<sup>a,b</sup>
</td>
<td>0/8</td>
<td>1.64 ± 0.06<sup>a,b</sup>
</td>
<td>0/8</td>
<td>2.01 ± 0.33<sup>d</sup>
</td>
<td>0/8</td>
<td>1.79 ± 0.04<sup>a,b</sup>
</td>
</tr>
<tr>
<td>24</td>
<td>0/8</td>
<td>2.93 ± 0.17</td>
<td>0/8</td>
<td>2.42 ± 0.09<sup>a</sup>
</td>
<td>0/8</td>
<td>1.42 ± 0.17<sup>a,b</sup>
</td>
<td>4/8</td>
<td>1.60 ± 0.10<sup>a,b</sup>
</td>
<td>0/8</td>
<td>2.38 ± 0.09<sup>a,c,d</sup>
</td>
<td>0/8</td>
<td>2.56 ± 0.04<sup>a,c,d</sup>
</td>
<td>1/8</td>
<td>1.17 ± 0.03<sup>a,b,d,e,f</sup>
</td>
</tr>
<tr>
<td>30</td>
<td>1/8</td>
<td>4.13 ± 0.44</td>
<td>0/8</td>
<td>2.63 ± 0.14<sup>a</sup>
</td>
<td>0/8</td>
<td>1.57 ± 0.03<sup>a,b</sup>
</td>
<td>8/8</td>
<td>0.67 ± 0.03<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>3.51 ± 0.02<sup>a,b,c,d</sup>
</td>
<td>0/8</td>
<td>3.38 ± 0.21<sup>a,b,c,d</sup>
</td>
<td>2/8</td>
<td>2.00 ± 0.08<sup>a,b,d,e,f</sup>
</td>
</tr>
<tr>
<td>36</td>
<td>2/8</td>
<td>5.52 ± 0.49</td>
<td>0/8</td>
<td>2.89 ± 0.05<sup>a</sup>
</td>
<td>0/8</td>
<td>2.88 ± 0.13<sup>a</sup>
</td>
<td>
</td>
<td>
</td>
<td>0/8</td>
<td>4.25 ± 0.84<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>3.74 ± 0.06<sup>a</sup>
</td>
<td>5/8</td>
<td>2.13 ± 0.10<sup>a,e,f</sup>
</td>
</tr>
<tr>
<td>42</td>
<td>3/8</td>
<td>7.74 ± 0.18</td>
<td>0/8</td>
<td>2.95 ± 0.07<sup>a</sup>
</td>
<td>0/8</td>
<td>3.47 ± 0.18<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
<td>0/8</td>
<td>4.70 ± 0.13<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>3.65 ± 0.14<sup>a,b,e</sup>
</td>
<td>6/8</td>
<td>2.18 ± 0.10<sup>a,b,c,e,f</sup>
</td>
</tr>
<tr>
<td>48</td>
<td>3/8</td>
<td>8.92 ± 0.23</td>
<td>1/8</td>
<td>3.04 ± 0.04<sup>a</sup>
</td>
<td>0/8</td>
<td>3.74 ± 0.16<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
<td>2/8</td>
<td>5.02 ± 0.25<sup>a,b,c</sup>
</td>
<td>0/8</td>
<td>3.88 ± 0.08<sup>a,b,e</sup>
</td>
<td>8/8</td>
<td>2.61 ± 0.06<sup>a,c,e,f</sup>
</td>
</tr>
<tr>
<td>54</td>
<td>5/8</td>
<td>9.27 ± 0.28</td>
<td>2/8</td>
<td>3.43 ± 0.07<sup>a</sup>
</td>
<td>1/8</td>
<td>4.73 ± 0.20<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
<td>2/8</td>
<td>5.14 ± 0.09<sup>a,b</sup>
</td>
<td>0/8</td>
<td>4.77 ± 0.17<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>60</td>
<td>8/8</td>
<td>9.50 ± 0.17</td>
<td>2/8</td>
<td>3.66 ± 0.14<sup>a</sup>
</td>
<td>2/8</td>
<td>4.90 ± 0.14<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
<td>3/8</td>
<td>5.21 ± 0.04<sup>a,b</sup>
</td>
<td>1/8</td>
<td>4.90 ± 0.06<sup>a,b</sup>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>66</td>
<td>
</td>
<td>
</td>
<td>4/8</td>
<td>3.97 ± 0.05</td>
<td>2/8</td>
<td>5.24 ± 0.03<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
<td>4/8</td>
<td>5.24 ± 0.18<sup>b</sup>
</td>
<td>3/8</td>
<td>5.09 ± 0.13<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>72</td>
<td>
</td>
<td>
</td>
<td>5/8</td>
<td>4.29 ± 0.05</td>
<td>4/8</td>
<td>5.34 ± 0.06<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
<td>6/8</td>
<td>5.37 ± 0.02<sup>b</sup>
</td>
<td>5/8</td>
<td>5.21 ± 0.29<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>78</td>
<td>
</td>
<td>
</td>
<td>8/8</td>
<td>4.30 ± 0.15</td>
<td>6/8</td>
<td>5.27 ± 0.03<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
<td>8/8</td>
<td>5.49 ± 0.25<sup>b</sup>
</td>
<td>6/8</td>
<td>5.43 ± 0.50<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>84</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>8/8</td>
<td>5.38 ± 0.11</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>8/8</td>
<td>5.80 ± 0.11</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>MTW</td>
<td align="center" colspan="2">5.74</td>
<td align="center" colspan="2">3.08</td>
<td align="center" colspan="2">3.60</td>
<td align="center" colspan="2">1.23</td>
<td align="center" colspan="2">4.11</td>
<td align="center" colspan="2">3.99</td>
<td align="center" colspan="2">1.87</td>
</tr>
<tr>
<td>MST (days)</td>
<td align="center" colspan="2">45</td>
<td align="center" colspan="2">63</td>
<td align="center" colspan="2">69</td>
<td align="center" colspan="2">23.5</td>
<td align="center" colspan="2">63</td>
<td align="center" colspan="2">72</td>
<td align="center" colspan="2">36</td>
</tr>
<tr>
<td>ILS (%)</td>
<td align="center" colspan="2">–</td>
<td align="center" colspan="2">140</td>
<td align="center" colspan="2">153.33</td>
<td align="center" colspan="2">58.88</td>
<td align="center" colspan="2">140</td>
<td align="center" colspan="2">160</td>
<td align="center" colspan="2">80</td>
</tr>
<tr>
<td>T/C (%)</td>
<td align="center" colspan="2">–</td>
<td align="center" colspan="2">46.3</td>
<td align="center" colspan="2">37.2</td>
<td align="center" colspan="2">78.5</td>
<td align="center" colspan="2">28.4</td>
<td align="center" colspan="2">30.4</td>
<td align="center" colspan="2">67.4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711434955">
<p>PTI: post-tumor inoculation; M: mortality; MTW: mean tumor weight (g); MST (days): mean survival time; ILS: increase of life span; T/C: tumor inhibition ratio; DOX: doxorubicin; T: tumor group; TTX: tetrodotoxin; NAC: <italic>N</italic>-acetylcysteine; SE: standard error.</p>
</fn>
<fn id="table-fn2-0748233711434955">
<p>
<sup>a</sup>Significant change from tumor group (T).</p>
</fn>
<fn id="table-fn3-0748233711434955">
<p>
<sup>b</sup>Significant change from (T + DOX) group.</p>
</fn>
<fn id="table-fn4-0748233711434955">
<p>
<sup>c</sup>Significant change from (T + TTX) group.</p>
</fn>
<fn id="table-fn5-0748233711434955">
<p>
<sup>d</sup>Significant change from (T + TTX + DOX) group.</p>
</fn>
<fn id="table-fn6-0748233711434955">
<p>
<sup>e</sup>Significant change from (T + NAC + DOX) group.</p>
</fn>
<fn id="table-fn7-0748233711434955">
<p>
<sup>f</sup>Significant change from (T + NAC + TTX) group at <italic>p</italic> ≤ 0.05. </p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section22-0748233711434955">
<title>Biochemical studies</title>
<p>The data presented in <xref ref-type="table" rid="table2-0748233711434955">Table 2</xref> reveals a significant increase (<italic>p</italic> &lt; 0.05) in liver caspase-3, TNF-α, GGT and plasma G6PHD in tumor-bearing mice when compared with the normal control mice. Treatment with TTX, DOX, NAC + DOX, NAC + TTX and NAC + TTX + DOX markedly reduced these levels when compared with tumor-bearing mice. All the groups exhibited a significant decrease in the level of plasma glucose in comparison with the control mice (<italic>p</italic> &lt; 0.05). <xref ref-type="table" rid="table3-0748233711434955">Table 3</xref> shows that the activities of liver SOD, GST and GSH decreased significantly, while the activity of GPX and MDA content significantly increased in the tumor-bearing mice in comparison with the control mice. Treatment with TTX, DOX, TTX + DOX, NAC + DOX, NAC + TTX and NAC + TTX + DOX significantly increased the level of activity of liver SOD, GST and GSH when compared with the tumor group. Also, all the treated groups exhibited a marked increase in liver GPX and MDA content (<italic>p</italic> &lt; 0.05) when compared with tumor mice.</p>
<table-wrap id="table2-0748233711434955" position="float">
<label>Table 2.</label>
<caption>
<p>Liver Caspase-3 (micromoles para-nitroaniline (PNA) per minute per milligram protein), liver TNF-α (ng/g wet tissue), liver GGT (U/g), plasma glucose-6-phosphate dehydrogenase (U/ml) and plasma glucose (mg/dl) of control, tumor-bearing mice and treated tumor-bearing mice.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0748233711434955" xlink:href="10.1177_0748233711434955-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Groups</th>
<th>Caspase-3</th>
<th>TNF-α</th>
<th>GGT</th>
<th>Glucose-6-phosphate</th>
<th>Glucose</th>
</tr>
</thead>
<tbody>
<tr>
<td>G1</td>
<td>Control</td>
<td>0.74 ± 0.05</td>
<td>2015.00 ± 91.13</td>
<td>20.13 ± 2.15</td>
<td>1.66 ± 0.07</td>
<td>164.58 ± 6.97</td>
</tr>
<tr>
<td>G2</td>
<td>Tumor (T)</td>
<td>12.00 ± 1.02<sup>b</sup>
</td>
<td>4960.00 ± 222.71<sup>b</sup>
</td>
<td>150.21 ± 4.60<sup>b</sup>
</td>
<td>6.55 ± 0.28<sup>b</sup>
</td>
<td>135.41 ± 8.01<sup>b</sup>
</td>
</tr>
<tr>
<td>G3</td>
<td>T + DOX </td>
<td>6.33 ± 0.27<sup>b,c</sup>
</td>
<td>4480.00 ± 98.79<sup>b</sup>
</td>
<td>44.71 ± 1.42<sup>b,c</sup>
</td>
<td>4.22 ± 0.12<sup>b,c</sup>
</td>
<td>66.66 ± 5.51<sup>b,c</sup>
</td>
</tr>
<tr>
<td>G4</td>
<td>T + TTX</td>
<td>9.93 ± 0.40<sup>b,d</sup>
</td>
<td>2975.00 ± 104.61<sup>b–d</sup>
</td>
<td>36.09 ± 1.92<sup>b–d</sup>
</td>
<td>2.58 ± 0.09<sup>b–d</sup>
</td>
<td>72.91 ± 4.75<sup>b,c</sup>
</td>
</tr>
<tr>
<td>G5</td>
<td>T + TTX + DOX</td>
<td>8.37 ± 0.66<sup>b,c</sup>
</td>
<td>3200.00 ± 243.92<sup>b–d</sup>
</td>
<td>24.63 ± 0.92<sup>c–e</sup>
</td>
<td>2.25 ± 0.07<sup>b–d</sup>
</td>
<td>127.08 ± 10.54<sup>b,d,e</sup>
</td>
</tr>
<tr>
<td>G6</td>
<td>T + NAC + DOX</td>
<td>6.33 ± 0.67<sup>b,c,e</sup>
</td>
<td>2175.00 ± 178.95<sup>c–f</sup>
</td>
<td>29.20 ± 0.61<sup>b–e</sup>
</td>
<td>3.94 ± 0.11<sup>b,c,e,f</sup>
</td>
<td>134.37 ± 11.49<sup>b,d,e</sup>
</td>
</tr>
<tr>
<td>G7</td>
<td>T + NAC + TTX</td>
<td>11.19 ± 0.57<sup>b,d,f,g</sup>
</td>
<td>2400.00 ± 219.08<sup>c–f</sup>
</td>
<td>34.22 ± 0.80<sup>b,c,d,f</sup>
</td>
<td>4.08 ± 0.12<sup>b,c,e,f</sup>
</td>
<td>56.25 ± 3.60<sup>b,c,f,g</sup>
</td>
</tr>
<tr>
<td>G8</td>
<td>T + NAC + TTX + DOX</td>
<td>12.33 ± 1.39<sup>b,d,e,f,g</sup>
</td>
<td>2360.00 ± 198.19<sup>c–f</sup>
</td>
<td>20.97 ± 0.61<sup>c,d,e,g,h</sup>
</td>
<td>2.38 ± 0.11<sup>b,c,d,g,h</sup>
</td>
<td>75.00 ± 6.65<sup>b,c,f,g</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0748233711434955">
<p>TNF-α: tumor necrosis factor-α; GGT: γ-glutamyltransferase; DOX: doxorubicin; T: tumor group; TTX: tetrodotoxin.</p>
</fn>
<fn id="table-fn9-0748233711434955">
<p>
<sup>a</sup>The results are presented as mean of six mice ± standard error.</p>
</fn>
<fn id="table-fn10-0748233711434955">
<p>
<sup>b</sup>Significant change from control group.</p>
</fn>
<fn id="table-fn11-0748233711434955">
<p>
<sup>c</sup>Significant change from tumor group.</p>
</fn>
<fn id="table-fn12-0748233711434955">
<p>
<sup>d</sup>Significant change from DOX group.</p>
</fn>
<fn id="table-fn13-0748233711434955">
<p>
<sup>e</sup>Significant change from TTX group.</p>
</fn>
<fn id="table-fn14-0748233711434955">
<p>
<sup>f</sup>Significant change from TTX and DOX group.</p>
</fn>
<fn id="table-fn15-0748233711434955">
<p>
<sup>g</sup>Significant change from NAC and DOX group.</p>
</fn>
<fn id="table-fn16-0748233711434955">
<p>
<sup>h</sup>Significant change from NAC and TTX group at <italic>p</italic> &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0748233711434955" position="float">
<label>Table 3.</label>
<caption>
<p>Levels of liver SOD (µg/gm), GPX (mg/g), GST (conjugate 1-chloro-2,4-dinitrobenzene (CDNB) per minute per milligram tissue; µm/mg/min), GSH (mg/g tissue) and MDA (nmol/gm) of control, tumor-bearing mice and treated tumor-bearing mice.<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table3-0748233711434955" xlink:href="10.1177_0748233711434955-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Groups</th>
<th>SOD</th>
<th>GPX</th>
<th>GST</th>
<th>GSH</th>
<th>MDA</th>
</tr>
</thead>
<tbody>
<tr>
<td>G1</td>
<td>Control</td>
<td>438.90 ± 8.62</td>
<td>624.57 ± 22.10</td>
<td>5.88 ± 0.21</td>
<td>24.44 ± 1.28</td>
<td>36.08 ± 1.45</td>
</tr>
<tr>
<td>G2</td>
<td>Tumor (T)</td>
<td>376.65 ± 10.42<sup>b</sup>
</td>
<td>803.84 ± 23.81<sup>b</sup>
</td>
<td>2.96 ± 0.06<sup>b</sup>
</td>
<td>9.88 ± 0.31<sup>b</sup>
</td>
<td>202.67 ± 3.47<sup>b</sup>
</td>
</tr>
<tr>
<td>G3</td>
<td>T + DOX</td>
<td>349.59 ± 8.07<sup>b,c</sup>
</td>
<td>786.22 ± 27.66<sup>b</sup>
</td>
<td>4.17 ± 0.17<sup>b,c</sup>
</td>
<td>14.66 ± 0.38<sup>b,c</sup>
</td>
<td>174.07 ± 7.19<sup>b,c</sup>
</td>
</tr>
<tr>
<td>G4</td>
<td>T + TTX</td>
<td>415.83 ± 5.28<sup>b–d</sup>
</td>
<td>754.47 ± 23.51<sup>b</sup>
</td>
<td>3.81 ± 0.13<sup>b,c</sup>
</td>
<td>34.55 ± 1.51<sup>b–d</sup>
</td>
<td>134.74 ± 4.10<sup>b–e</sup>
</td>
</tr>
<tr>
<td>G5</td>
<td>T + TTX + DOX</td>
<td>317.22 ± 6.23<sup>b–e</sup>
</td>
<td>787.85 ± 25.66<sup>b</sup>
</td>
<td>4.62 ± 0.11<sup>b–e</sup>
</td>
<td>11.99 ± 0.76<sup>b–e</sup>
</td>
<td>108.55 ± 1.80<sup>b–e</sup>
</td>
</tr>
<tr>
<td>G6</td>
<td>T + NAC + DOX</td>
<td>360.38 ± 5.61<sup>b,e,f</sup>
</td>
<td>785.99 ± 20.32<sup>b</sup>
</td>
<td>3.63 ± 0.01<sup>b,c,d,f</sup>
</td>
<td>8.88 ± 0.28<sup>b,d,e,f</sup>
</td>
<td>192.23 ± 6.20<sup>b,d,e,f</sup>
</td>
</tr>
<tr>
<td>G7</td>
<td>T + NAC + TTX</td>
<td>335.65 ± 4.52<sup>b,c,e,g</sup>
</td>
<td>874.06 ± 35.83<sup>b,d–g</sup>
</td>
<td>4.46 ± 0.08<sup>b,c,e,g</sup>
</td>
<td>27.77 ± 0.87<sup>b–g</sup>
</td>
<td>137.74 ± 5.05<sup>b–d,f,g</sup>
</td>
</tr>
<tr>
<td>G8</td>
<td>T + NAC + TTX + DOX</td>
<td>315.40 ± 8.68<sup>b–e,g</sup>
</td>
<td>807.43 ± 15.99<sup>b</sup>
</td>
<td>4.34 ± 0.15<sup>b,c,e</sup>
</td>
<td>15.22 ± 0.49<sup>b,c,e,f–h</sup>
</td>
<td>130.49 ± 5.40<sup>b–d,f,g</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn17-0748233711434955">
<p>SOD: superoxide dismutase; GPX: glutathione peroxidase; GST: glutathione <italic>S</italic>-transferase; GSH: glutathione; MDA: malondialdehyde; DOX: doxorubicin; T: tumor group; TTX: tetrodotoxin.</p>
</fn>
<fn id="table-fn18-0748233711434955">
<p>
<sup>a</sup>The results are presented as mean of six mice ± standard error.</p>
</fn>
<fn id="table-fn19-0748233711434955">
<p>
<sup>b</sup>Significant change from control group.</p>
</fn>
<fn id="table-fn20-0748233711434955">
<p>
<sup>c</sup>Significant change from tumor group.</p>
</fn>
<fn id="table-fn21-0748233711434955">
<p>
<sup>d</sup>Significant change from DOX group.</p>
</fn>
<fn id="table-fn22-0748233711434955">
<p>
<sup>e</sup>Significant change from TTX group.</p>
</fn>
<fn id="table-fn23-0748233711434955">
<p>
<sup>f</sup>Significant change from TTX and DOX group.</p>
</fn>
<fn id="table-fn24-0748233711434955">
<p>
<sup>g</sup>Significant change from NAC and DOX group.</p>
</fn>
<fn id="table-fn25-0748233711434955">
<p>
<sup>h</sup>Significant change from NAC and TTX group at <italic>p</italic> &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section23-0748233711434955">
<title>Histological changes in liver tissue</title>
<p>Examination of liver sections of mice injected with EAC displayed severe changes in liver cells marked by wide dilatation in portal veins surrounded by leukocytic infiltration and presence of necrotic foci in the tissue surrounded concentric inflammatory infiltration (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(b)). Inspection of liver sections injected with DOX revealed some changes in the tissue demonstrated by wide dilatation in central vein with congestion of erythrocytes and leukocytes. Thickening in the central vein wall was observed due to the accumulation of fibers around the wall lining, which displayed complete separation in some areas and destruction in others (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(c) and (d)).</p>
<fig id="fig1-0748233711434955" position="float">
<label>Figure 1.</label>
<caption>
<p>Light micrograph of the liver sections. (a) Control liver with central vein (CV) and surrounding hepatocytes. (b) Liver sections of the group treated with Ehrlich tumor 24 days after Ehrlich cells injection with vacuolar degeneration (VD), inflammatory leukocytic infiltration (arrows) near a dilated portal vein (PV). (c) and (d) Liver sections of the group treated with DOX after 24 days of Ehrlich injection appearing with wide dilatation in central vein (CV) with congestion (C), thickening in its wall due to accumulation of fibers (arrows). Necrotic lesions (NL) in the tissue and aggregations of inflammatory cells (arrows) were displayed. (e) Liver sections of the group treated with TTX after 24 days of Ehrlich injection showing dilatation in portal vein (PV) surrounded by aggregations of inflammatory cells (In) besides necrotic lesions. (f) Liver sections of the group treated with TTX appearing with healthy hepatocytes around normal central vein (CV). (g) Liver sections of the group treated with TTX + DOX displayed wide dilatation in portal veins (PV) with accumulation of fibers (F) in its walls and also around bile duct. Large necrotic areas (NA) were found. (h) Liver sections of the group treated with NAC + DOX after 24 days of Ehrlich injection with large area of inflammatory infiltrative cells (In) besides the necrotic foci (Nf). Deposited layers of fibers (F) appeared in between infiltration cells. (i) Liver sections of the group treated with NAC + TTX with dilatation in central vein, necrotic lesions (arrows), leukocytic infiltration (In) and depositions of fibers (F). (j) Liver sections of the group treated with NAC + TTX + DOX showed deformation of the liver architecture, deposition of great amount of fibers (F) in necrotic areas and numerous aggregations of leukocytic inflammatory cells (In). Magnifications, ×200 ((a), (d), (e), (f), (i), and (j)) and ×100 ((b), (c) and (g)). DOX: doxorubicin; TTX: tetrodotoxin; NAC: <italic>N</italic>-acetylcysteine.</p>
</caption>
<graphic xlink:href="10.1177_0748233711434955-fig1.tif"/>
</fig>
<p>Examination of liver sections in mice injected with TTX showed necrotic foci in the tissue and dilatation of blood sinusoids. While other sections revealed an improvement in the liver tissue marked by the appearance of healthy hepatocytes arranged in some extent similar to that of the normal architecture (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(e) and (f)). The wall of portal veins was thickened due to the accumulation of concentric layers of fibers around the walls and also around the bile ducts. Moreover, great destruction in some areas of the wall surrounded by necrotic areas was noticed after treatment with TTX + DOX (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(g)).</p>
<p>Liver sections of mice injected with NAC + DOX revealed leukocytic inflammatory cells with necrotic foci and fibrous layers were deposited in the tissue (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(h)). Accumulation of fibers were deposited in necrotic lesions surrounded by inflammatory cells, in addition to dilated central vein with congestion noticed in the liver of mice treated with NAC + TTX (<xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(i)). Macroscopically, livers from the mice treated with NAC + TTX + DOX displayed dangerous effects on the liver marked by the accumulation of deposited fiber layers in necrotic lesions and scattering of great amounts of inflammatory cells as shown in <xref ref-type="fig" rid="fig1-0748233711434955">Figure 1</xref>(j).</p>
</sec>
</sec>
<sec id="section24-0748233711434955">
<title>Discussion</title>
<sec id="section25-0748233711434955">
<title>Antitumor studies</title>
<p>In the present study, treatment of tumor-bearing mice with DOX or TTX alone and with doses of DOX + TTX and/or NAC exerted a marked effect in the retardation of tumor growth. A more pronounced effect was observed in the single treatment with TTX, which is represented by higher increases in the life span of animals and the tumor inhibition ratio (37.2%). These observations are consistent with the previous findings by Fouda<xref ref-type="bibr" rid="bibr24-0748233711434955"> (2005</xref>) and supported by <xref ref-type="bibr" rid="bibr61-0748233711434955">Roger et al. (2004</xref>) and <xref ref-type="bibr" rid="bibr23-0748233711434955">Fernandes et al. (2006</xref>), as they reported that TTX has a great ability to bind to the transmembrane glycoprotein forming Na<sup>+</sup> channel that resulted in blocking it, hence reducing the proliferation, migration and invasive properties of the cell line by about 30%. The action mechanism of TTX on EAC is probably not different from that of other cells in the nervous system. It plays an important role in binding to <italic>p</italic>-glycoprotein of the Na<sup>+</sup> channels, blocking it and preventing Na<sup>+</sup> influx into the cells. This action, in turn, prevents the carcinoma cells from getting sufficient Na<sup>+</sup> ions for the requirements of various intracellular functions, and above all to maintain the normal charge distribution across the cell membrane, a process necessary to maintain cellular integrity. As a consequence, the proliferation and invasiveness of such cells are suppressed (<xref ref-type="bibr" rid="bibr9-0748233711434955">Bragadeeswaran et al., 2010</xref>).</p>
<p>The results of the present study also demonstrated that the treatment with DOX alone caused significant decrease in MTW and increases the mean survival time of tumor-bearing mice. This decrease in MTW may attribute to the action of DOX, which binds to DNA by intercalation and inhibits replication and transcription. So, it inhibited the proliferation of EAC cells as well as DNA synthesis and mitosis (<xref ref-type="bibr" rid="bibr32-0748233711434955">Gumushan and Musa, 2008</xref>; <xref ref-type="bibr" rid="bibr41-0748233711434955">Ivic et al., 2005</xref>; <xref ref-type="bibr" rid="bibr64-0748233711434955">Shi et al., 2009</xref>). Moreover, <xref ref-type="bibr" rid="bibr53-0748233711434955">Minotti et al. (2004</xref>) found that the mechanisms of action of DOX are multiple. First of all, it forms a covalent complex with DNA topoisomerase, thus preventing the activation of this enzyme. Second, DOX intercalates in the DNA bone and leads to single- or double-strand breaks. Third, hepatic metabolism of the drug leads to the production of oxygen reactive species, which, in turn, damages DNA and causes cell death.</p>
<p>The present investigation clearly demonstrated that the application of NAC with TTX or DOX to tumor-bearing mice had no effect on the action of both drugs. <xref ref-type="bibr" rid="bibr14-0748233711434955">De Flora and Albini (1997</xref>) found that the intravenous treatment of female mice with NAC and DOX, mixed together with the same injection, produced marked inhibition in the weight of primary tumors or in the mean number of lung metastases and improved the survival time of the mice.</p>
<p>In the current study, the increase in the tumor inhibition ratio accompanied by decline in ILS (%) treatment with doses of TTX + DOX and NAC + TTX + DOX may be due to short life span and damage to the liver and heart and also due to double oxidative stress of the two molecules. Such finding is in agreement with <xref ref-type="bibr" rid="bibr16-0748233711434955">Deepa and Varalakshmi (2003</xref>), who reported that DOX administration produces free radicals that cause destruction to cardiac membrane by increasing the lipid peroxidation, and also DOX causes death in animals by damaging several key organs, such as heart, liver and kidney (<xref ref-type="bibr" rid="bibr48-0748233711434955">Kramer et al., 2006</xref>). Also, <xref ref-type="bibr" rid="bibr10-0748233711434955">Callaway et al. (2001</xref>) explained the chemical structure of TTX molecule that contains positions with negative charge that can act as free radicals, and these free radicals induce increase in reactive oxygen species (ROS). However, the present findings are in line with the main concept of cancer research that evaluation of any tested substance depends on the extension of the survival time of cancer patients and that an increase in the life span of ≥125% in drug-treated tumor-bearing mice is considered indicative of presumptive drug activity (<xref ref-type="bibr" rid="bibr2-0748233711434955">Abd El-Dayem et al., 2010</xref>; <xref ref-type="bibr" rid="bibr21-0748233711434955">Fahim et al., 2003</xref>).</p>
</sec>
<sec id="section26-0748233711434955">
<title>Biochemical studies</title>
<p>In the present investigation, tumor-bearing mice showed higher increases in the activity of caspase-3, indicating increase in apoptosis. <xref ref-type="bibr" rid="bibr56-0748233711434955">O’Donovan et al. (2003)</xref> and <xref ref-type="bibr" rid="bibr15-0748233711434955">De Heer et al. (2007</xref>) found that the activity of caspase-3 was significantly higher in carcinomas tissue than in the corresponding normal tissue. Also, the activity of caspase-3 is increased in tumor cells due to the inactivation of p53 (tumor suppressor protein), which is responsible for protecting cells from tumorigenic alterations (<xref ref-type="bibr" rid="bibr60-0748233711434955">Ramnath et al., 2009</xref>). The elevation in the TNF-α level in tumor-bearing mice may be attributed to the increase in the production of ROS by macrophages, which stimulate lipid peroxidation and thought to have an important pathogenic role in the liver damage (<xref ref-type="bibr" rid="bibr36-0748233711434955">Hoek and Pastorino, 2002</xref>). In the present study, tumor-bearing mice showed a significant elevation in liver GGT, which may indicate the development of primary or secondary carcinoma. <xref ref-type="bibr" rid="bibr65-0748233711434955">Strasak et al. (2008)</xref> reported that GGT expression may be an early marker of neoplastic transformation.</p>
<p>The present data revealed a significant reduction in liver caspase-3-induced apoptosis as well as in the levels of GGT and TNF-α in TTX-treated groups. The obtained data are in parallel with the result of <xref ref-type="bibr" rid="bibr7-0748233711434955">Banasiak et al. (2004</xref>) who reported that reducing Na<sup>+</sup> entry with the voltage-sensitive sodium channels blocker, that is, TTX, attenuated apoptotic cell death via a reduction in caspase-3 activation. Several explanations were found for decreased caspase-3 and induction of apoptosis by TTX to block the Na<sup>+</sup> K<sup>+</sup>-pump (<xref ref-type="bibr" rid="bibr13-0748233711434955">Chueh et al., 2001</xref>). ROS production might contribute to the pump failure correlating with a more severe block of Na<sup>+</sup> K<sup>+</sup>-pump leading to apoptotic insults (<xref ref-type="bibr" rid="bibr72-0748233711434955">Wang et al., 2003</xref>). In support to these results, <xref ref-type="bibr" rid="bibr62-0748233711434955">Roselli et al. (2006</xref>) mentioned that Na<sup>+</sup> influx through voltage-gated sodium channel (VGSC) is required for lymphocyte activation and proliferation, since these responses are blocked by Na<sup>+</sup>-free medium or by VGSC blockers. The present results revealed that the dramatic reduction in DOX-induced activation of caspase-3 as well as the levels of liver GGT and TNF-α in DOX-treated groups may be due to early activation of p53 by DOX in both normal and tumor cell lines and prevented apoptosis in tumor cell lines. Such findings are in agreement with the results of <xref ref-type="bibr" rid="bibr69-0748233711434955">Tsang et al. (2005</xref>). Also, <xref ref-type="bibr" rid="bibr12-0748233711434955">Chua et al. (2006</xref>) reported that the activation of p53, which in turn promotes apoptosis of tumor cells, is considered to be a key mechanism of action of antitumor drugs, including DOX. <xref ref-type="bibr" rid="bibr75-0748233711434955">Wilson et al. (2004</xref>) attributed that decrease in the short-term expression of proinflammatory cytokines such as TNF-α can be beneficial to the heart.</p>
<p>Furthermore, tumor-bearing mice showed a significant decrease in the level of plasma glucose and significant increase in the activity of G6PHD. The decreased level of glucose could be explained by the high rate of glycolysis of tumors, regardless of whether their oxygen supply is adequate or low. This characteristic of tumor cells leads to a stringent dependence on extracellular glucose for maintaining intracellular levels of adenosine triphosphate (ATP) and may also be important in the acidification of the extracellular environment (<xref ref-type="bibr" rid="bibr21-0748233711434955">Fahim et al., 2003</xref>). The increased G6PHD could be explained by <xref ref-type="bibr" rid="bibr25-0748233711434955">Frederiks et al. (2007</xref>) who found that G6PHD expression is enhanced in tumor-bearing mice by oxidative stress induced by agents that either increase the intracellular concentration of O<sup>2</sup> or decrease the GSH pool.</p>
<p>Moreover, the deprivation of the plasma glucose in TTX-treated group could be ascribed primarily to Na<sup>+</sup> load and oxidative stress. The basis for this is an increased utilization of ATP by the Na<sup>+</sup> pump activated by a Na<sup>+</sup> entry coupled with the inability of mitochondria to respond adequately with increasing ATP production because of the limitation in respiratory capacity under oxidative stress (<xref ref-type="bibr" rid="bibr72-0748233711434955">Wang et al., 2003</xref>). In agreement with these observations, in the present work, it was found that a significant depletion of G6PHD in TTX-treated group could be due to severe oxidative stress, which has caused the inactivation of G6PHD that correlated with oxidative damage. Therefore, nicotinamide adenine dinucleotide phosphate (NADPH), the major cofactor produced by G6PHD/oxidative limb of the pentose phosphate cycle, is vital to cellular defense against oxidative stress (<xref ref-type="bibr" rid="bibr40-0748233711434955">Iraimoudi et al., 2002</xref>). However, in the present study, treatment with DOX induced a significant decrease in the levels of glucose and G6PHD in the plasma of treated mice. The decrease in glucose level agreed with the findings of <xref ref-type="bibr" rid="bibr37-0748233711434955">Hrelia et al. (2002</xref>). In cardiomyocytes, DOX treatment caused a maximal increase in glucose uptake at 1 h, demonstrating that glucose transport may represent an early target for DOX. Otherwise, the decrease in the levels of G6PHD in the plasma of mice treated with DOX may be due to the oxidation of proteins (riboses) that are critical for maintaining proper cellular functions, such as DNA repair. In addition, G6PHD is necessary for adequate NADPH production, which is utilized in the reduction of nucleotide diphosphates to deoxyribonucleic acids and is therefore necessary for synthesis of DNA as mentioned by <xref ref-type="bibr" rid="bibr6-0748233711434955">Ayene et al. (2002</xref>).</p>
<p>The present results recorded an increase in the hepatic MDA of tumor-bearing mice, which may indicate the development of primary and secondary carcinoma (<xref ref-type="bibr" rid="bibr74-0748233711434955">Whitby et al., 1993</xref>). Excessive production of free radicals results in the oxidative stress leading to the damage of macromolecules such as lipids and can induce lipid peroxidation <italic>in vivo</italic> (<xref ref-type="bibr" rid="bibr2-0748233711434955">Abd El-Dayem et al., 2010</xref>; <xref ref-type="bibr" rid="bibr33-0748233711434955">Gupta et al., 2004</xref>). The reduction in the levels of GSH in tumor-bearing mice may be attributed to increased rate of transformation of GSH to oxidized GSH as a result of GSH consumption to get rid of hydrogen peroxide. The other possible reason could be the inhibition of GSH synthesis or a lack of amino acids used in synthesizing GSH (<xref ref-type="bibr" rid="bibr59-0748233711434955">Pompella et al., 2007</xref>). The present study recorded significant elevations in the hepatic GPX as well as depletion in the levels of SOD and GST of tumor-bearing mice when compared with normal mice. Such finding is in agreement with <xref ref-type="bibr" rid="bibr55-0748233711434955">Navarro et al. (1999</xref>) and <xref ref-type="bibr" rid="bibr21-0748233711434955">Fahim et al. (2003</xref>). They reported that the increase in the GPX and decrease in SOD and GST is due to the oxidative stress on the host in response to the continual generation of free radicals by the increasing tumor load.</p>
<p>In the present investigation, treatment with TTX induced a significant increase in liver GSH and MDA contents. These results could be explained from the chemical structure of TTX molecule, which contain positions with negative charge that can act as free radicals. These free radicals may induce increase in ROS (<xref ref-type="bibr" rid="bibr10-0748233711434955">Callaway et al., 2001</xref>). In this line, <xref ref-type="bibr" rid="bibr26-0748233711434955">Fukuda et al. (2005</xref>) found that the oxidative stress reduces Na channel availability, which could explain the significant increase in the level of MDA in TTX-treated mice when compared with the control. In the present investigation, TTX treatment caused a significant reduction in GPX and GST and an increase in the activities of SOD. A possible explanation for TTX protection and decreasing ROS was supported by <xref ref-type="bibr" rid="bibr27-0748233711434955">Garciarena et al. (2008</xref>), who reported that the existence of a direct mitochondrial action of Na<sup>+</sup>/H<sup>+</sup> exchanger 1 (NHE-1) inhibitors in preventing ROS release. They concluded that a mitochondrial action of NHE-1 inhibitors should lead to revisit or reinterpret previous landmark observations about their beneficial effect in several cardiac diseases.</p>
<p>The present findings indicated that the level of MDA and GSH was significantly increased in comparison with the carcinogenic group in the DOX-treated group. This increase may be due to the metabolism of DOX, which lead to the release of iron ions. These ions, therefore, become more reactive in liver (<xref ref-type="bibr" rid="bibr44-0748233711434955">Kalender et al., 2005</xref>; <xref ref-type="bibr" rid="bibr64-0748233711434955">Shi et al., 2009</xref>). Free iron ions released from iron-containing proteins participate in the generation of hydroxyl radicals (Catala, <xref ref-type="bibr" rid="bibr11-0748233711434955">2009</xref>). <xref ref-type="bibr" rid="bibr63-0748233711434955">Salvemini et al. (1999</xref>) reported that GSH synthesis was shown to be induced in cells exposed to oxidative stress as an adaptive process. On the other hand, in the present results, the possible reasons for the lowered activities of GPX and SOD of the liver tissue treated with DOX might be due to the inhibition of enzyme protein synthesis as well as the inhibition of enzymes by DOX, metabolites or some lipid peroxidation products (<xref ref-type="bibr" rid="bibr54-0748233711434955">Mukherjee et al., 2003</xref>). Furthermore, <xref ref-type="bibr" rid="bibr2-0748233711434955">Abd El-Dayem et al. (2010</xref>) stated that DOX affects liver cells and thus produces free oxygen radicals and causes hepatotoxicity. This explanation is consistent with the present work, which showed that DOX has dangerous histological effects on the liver reflected by the appearance of dilatation with congestion and thickening in the central vein wall due to the accumulation of fibers, and leukocytic infiltration was abundant in addition to necrotic lesions that were scattered in the tissue. The increased activity of liver GST in DOX-treated group was explained by <xref ref-type="bibr" rid="bibr30-0748233711434955">Goto et al. (2001</xref>) who attributed to the findings of increased expression of GST, an isozyme of GST, that has been found in the nucleus of cancer cells resistant to DOX and protected DNA from damage by anticancer drugs. In the same trend, <xref ref-type="bibr" rid="bibr17-0748233711434955">Doi et al. (2004</xref>) reported that increased GST-π expression in normal and tumor cells may protect them against drug-induced oxidative stress and, thus, apoptosis.</p>
<p>Both TTX and DOX drugs have oxidative stress mechanism as discussed above (<xref ref-type="bibr" rid="bibr44-0748233711434955">Kalender et al., 2005</xref>; <xref ref-type="bibr" rid="bibr64-0748233711434955">Shi et al., 2009</xref>; <xref ref-type="bibr" rid="bibr72-0748233711434955">Wang et al., 2003</xref>). Another explanation for the mechanism of the two drugs was suggested by <xref ref-type="bibr" rid="bibr67-0748233711434955">Tandon et al. (2005</xref>) who showed that oxidative stress is not always detrimental, as it can sometimes be beneficial in cancer. Hence, oxidative stress can act as a double-way sword in malignant states. Their theory was in same trend with the present results, where treatment with each of the two drugs TTX or DOX alone induced a significant improvement in the cancer stage and decrease in ROS, but TTX is more effective. However, treatment with TTX + DOX induced a high damage to the mice and less effect than each drug alone through all investigated biochemical parameters.</p>
</sec>
<sec id="section27-0748233711434955">
<title>Histological studies</title>
<p>Histopathological alterations and congestion in the liver tissue of mice treated with TTX were observed by Yamaguchi (<xref ref-type="bibr" rid="bibr76-0748233711434955">1996</xref>). Administration of TTX offers some protection to the liver, which is revealed by decreasing the levels of liver marker enzymes (GGT and TNF-α) and increasing the level of nonprotein thiols (GSH and GST). This may be due to the higher efficacy of TTX in scavenging various free radicals as supported by Fouda (<xref ref-type="bibr" rid="bibr24-0748233711434955">2005</xref>). The present results coincide with the results of Abd El-Wahab and Fouda (<xref ref-type="bibr" rid="bibr1-0748233711434955">2009</xref>), as they found that no detectable structural changes in the liver tissue of mice injected with 1/20 LD of TTX. Also, Lu and Cederbaum (<xref ref-type="bibr" rid="bibr51-0748233711434955">2006</xref>) recorded that no necrosis was observed in liver tissue from mice treated with cisplatin. The present work demonstrated that DOX has dangerous effects on the liver. Most of the previous mentioned alterations in the liver tissue, as a consequence of DOX application, showed similarity and confirmed those reported in rats (<xref ref-type="bibr" rid="bibr19-0748233711434955">El-sayyad et al., 2009</xref>; <xref ref-type="bibr" rid="bibr22-0748233711434955">Fang et al., 2004</xref>). It is also evident from the histopathological changes of the present results, where acute to chronic infiltration of phagocytic cells around the portal tract of the liver and in the tissue was found, indicating inflammation in this organ due to TTX- and DOX-induced oxidative burden. Also, oxidative stress-induced lipid peroxidation has been implicated in malignant transformation (Gonzalez, <xref ref-type="bibr" rid="bibr29-0748233711434955">1999</xref>). In addition, enhanced lipid peroxidation are concomitant with the decrease in reduced GPX, which is indicative of oxidative stress that provides evidence of the relationship between lipid peroxidation, tissue damage and inflammation (<xref ref-type="bibr" rid="bibr28-0748233711434955">Geetha et al., 2001</xref>).</p>
</sec>
</sec>
<sec id="section28-0748233711434955">
<title>Conclusions</title>
<p>This study has demonstrated that TTX had a more powerful inhibitory effect on EAC growth and fewer side effects than DOX reflected through increasing life span of mice and decreasing MTW. This effect may be due to the increased hepatic antioxidant activities; therefore, TTX may be useful as a new natural therapeutic for cancer. Also, the present data do not encourage the treatment of TTX with DOX together in the same time to get a strong and synergetic effect to each other.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>The authors thank Dr Karima Meaawad, Department of Zoology, Faculty of Women’s for Arts, Science and Education, Ain Shams University, for helping in histology in this work.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn2-0748233711434955"><label>Conflict of interest</label>
<p>The authors declared no conflicts of interest</p>
</fn>
<fn fn-type="financial-disclosure" id="fn1-0748233711434955"><label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El-Wahab</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Fouda</surname>
<given-names>FM</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Histological and histochemical study on the effect of Ehrlich ascites carcinoma on the liver and kidney of mice and the possible protective role of tetrodotoxin</article-title>. <source>Egyptian Journal of Biology</source> <volume>11</volume>: <fpage>13</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El-Dayem</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Fouda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Helal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zaazaa</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>The role of Catechin against doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma cells (EAC) bearing mice</article-title>. <source>American Journal of Science</source> <volume>6</volume>(<issue>4</issue>): <fpage>146</fpage>–<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aleisa</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Al-Rejaie</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Bakheet</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Al-Bekari</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Al-Shabanah</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Al-Maged</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>) <article-title>Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice</article-title>. <source>Mutagen</source> <volume>634</volume>
<issue>(1–2)</issue>: <fpage>93</fpage>–<fpage>100</fpage>.</citation>
</ref>
<ref id="bibr4-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arcamone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cassinelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fantini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grein</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Orezzi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pol</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> (<year>1969a</year>) <article-title>Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from <italic>S. Peucetius</italic> var. caesius</article-title>. <source>Biotechnology and Bioengineering</source> <volume>11</volume>(<issue>6</issue>): <fpage>1101</fpage>–<lpage>1110</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arcamone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Penco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Selva</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1969b</year>) <article-title>Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic</article-title>. <source>Tetrahedron Letters</source> <volume>13</volume>: <fpage>1007</fpage>–<lpage>1425</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayene</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Stamato</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Mauldin</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Biaglow</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Tuttle</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>SF</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>) <article-title>Mutation in the glucose-6-phosphate dehydrogenase gene leads to inactivation of Ku DNA end binding during oxidative stress</article-title>. <source>Journal of Biological Chemistry</source> <volume>277</volume>(<issue>12</issue>): <fpage>9929</fpage>–<lpage>9993</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banasiak</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Burenkova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>GG</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death</article-title>. <source>The Journal of Neuroscience</source> <volume>126</volume>(<issue>1</issue>): <fpage>31</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beutler</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duron</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>BM</given-names>
</name>
</person-group> (<year>1963</year>) <article-title>Improved method of the determination of blood glutathione</article-title>. <source>Journal of Laboratory and Clinical Medicine</source> <volume>61</volume>(<issue>5</issue>): <fpage>882</fpage>–<lpage>888</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bragadeeswaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Therasa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kathiresan</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Biomedical and harmacological potential of tetrodotoxin-producing bacteria isolated from marine pufferfish <italic>Arothron hispidu</italic>s (Muller, 1841)</article-title>. <source>The Journal of Venomous Animals and Toxins including Tropical Diseases</source> <volume>16</volume>(<issue>3</issue>): <comment>Botucatu</comment>.</citation>
</ref>
<ref id="bibr10-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callaway</surname>
<given-names>J K</given-names>
</name>
<name>
<surname>Beart</surname>
<given-names>P M</given-names>
</name>
<name>
<surname>Jarrott</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Giardina</surname>
<given-names>SF</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis</article-title>. <source>British Journal of Pharmacology</source> <volume>132</volume>(<issue>8</issue>): <fpage>1691</fpage>–<lpage>1698</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catala</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions</article-title>. <source>Chemistry and Physics of Lipids</source> <volume>157</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chua</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamdy</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>BHL</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells</article-title>. <source>American Journal of Physiology–Heart and Circulatory Physiology</source> <volume>290</volume>(<issue>6</issue>): <fpage>H2606</fpage>–<lpage>H2613</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chueh</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Guh</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>CM</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells</article-title>. <source>Journal of Urology</source> <volume>166</volume>(<issue>1</issue>): <fpage>347</fpage>–<lpage>353</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Flora</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Albini</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Pharmaceutical composition enabling to inhibit cancer metastasis formation containing <italic>N</italic>-acetyle-<sc>l</sc>-cysteine and doxorubicin. Zambon Group S.P.A (IT)</article-title> MI960277 A 14-Feb-1996.</citation>
</ref>
<ref id="bibr15-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Heer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>De Bruin</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Kranenbarg</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Aalbers</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Marijnen</surname>
<given-names>CAM</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <collab collab-type="author">Dutch Colorectal Cancer Group</collab> (<year>2007</year>) <article-title>Caspase-3 activity predicts local recurrence in rectal cancer</article-title>. <source>Clinical Cancer Research</source> <volume>13</volume>(<issue>19</issue>): <fpage>5810</fpage>–<lpage>5815</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deepa</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Varalakshmi</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity</article-title>. <source>Chemico-Biological Interactions</source> <volume>146</volume>(<issue>2</issue>): <fpage>201</fpage>–<lpage>210</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamazato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>) <article-title>Clinical characteristics relevant to myocardial cell apoptosis: analysis of pericardial fluid</article-title>. <source>Interactive CardioVascular and Thoracic Surgery</source> <volume>3</volume>: <fpage>359</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Drury</surname>
<given-names>BAR</given-names>
</name>
<name>
<surname>Wallington</surname>
<given-names>AE</given-names>
</name>
</person-group> (<year>1980</year>) <source>Carleton's Histological Technique</source>. <edition>5th ed</edition>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr19-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-sayyad</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Shalaby</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Abou-El-Magd</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Gaur</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Augusta</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>) <article-title>Histopathological effects of cisplatin, doxorubicin and 5-fluracil(5-FU) on the liver of male albino rats</article-title>. <source>International Journal of Biological Sciences</source> <volume>5</volume>: <fpage>466</fpage>–<lpage>473</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahim</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Esmat</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Mady</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>MA</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Serum LDH and ALP isozyme activities in mice bearing solid Ehrlich carcinoma and/or treated with maximum tolerated dose (MTD) of a loin</article-title>. <source>Disease Markers</source> <volume>13</volume>: <fpage>183</fpage>–<lpage>193</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahim</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Esmat</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Mady</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>EK</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Antitumor activities of iodoacetate and di methylsulphoxide against solid Ehrlich carcinoma growth in mice</article-title>. <source>Biological Research</source> <volume>36</volume>: <fpage>253</fpage>–<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>RCH</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Effect of O-4-ethoxyl-butyl-berbamine in combination with pegylated liposomal doxorubicin on advanced hepatoma in mice</article-title>. <source>World Journal of Gastroenterology</source> <volume>10</volume>(<issue>7</issue>): <fpage>950</fpage>–<lpage>953</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CA</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Eating habits: are we safe to consume freshwater puffer fish from the amazon region in Brazil</article-title>. <source>The Journal of Venomous Animals and Toxins including Tropical Diseases</source> <volume>12</volume>(<issue>2</issue>): <fpage>153</fpage>–<lpage>155</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fouda</surname>
<given-names>FM</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Anti-tumor activity of tetrodotoxin extracted from the masked puffer fish <italic>Arothron diadematus</italic></article-title>. <source>Egyptian Journal of Biology</source> <volume>7</volume>: <fpage>10</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frederiks</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Sindelárová</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Van Noorden</surname><given-names>CJF</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Loss of peroxisomes causes oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity to detect cancer cells</article-title>. <source>Journal of Histochemistry and Cytochemistry</source> <volume>55</volume>(<issue>2</issue>): <fpage>175</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Kupershmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fessel</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>) <article-title>Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels</article-title>. <source>Circulation Research</source> <volume>97</volume>: <fpage>1262</fpage>–<lpage>1269</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garciarena</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Caldiz</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Schinella</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Chiappe de Cingolani</surname>
<given-names>GE</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>) <article-title>Na<sup>+</sup>/H<sup>+</sup> exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action</article-title>. <source>Journal of Applied Physiology</source> <volume>105</volume>: <fpage>1706</fpage>–<lpage>1713</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geetha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Karthiga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Surendran</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jayalakshmi</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Biochemical studies on the level of lipid hydroperoxide and antioxidants in different types of obstructive jaundice</article-title>. <source>Journal of Laboratory and Clinical Medicine</source> <volume>2</volume>: <fpage>20</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>RA</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Free radicals, oxidative stress and DNA metabolism in human cancer</article-title>. <source>Cancer Investigation</source> <volume>17</volume>: <fpage>376</fpage>–<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ihara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Urata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Koji</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>) <article-title>Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione <italic>S</italic>-transferase π</article-title>. <source>The FASEB Journal</source> <volume>15</volume>: <fpage>2702</fpage>–<lpage>2714</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gross</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Bracci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rudolph</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kochen</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1967</year>) <article-title>Hydrogen peroxide toxicity and detoxification in the erythrocytes of new born infants</article-title>. <source>Blood</source> <volume>29</volume>(<issue>4</issue>): <fpage>481</fpage>–<lpage>493</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gumushan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Musa</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Effect of adriamycin administered via different routes on Ehrlich ascites tumor cells</article-title>. <source>IUFS Journal of Biology</source> <volume>67</volume>(<issue>1</issue>): <fpage>49</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mazumder</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>TS</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Anti-tumor activity and anti-oxidant role of <italic>Bauhinia racemosa</italic> against Ehrlich ascites carcinoma in Swiss albino mice</article-title>. <source>Acta Pharmacologica Sinica</source> <volume>25</volume>(<issue>8</issue>): <fpage>1070</fpage>–<lpage>1076</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habig</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Pabst</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jakoby</surname>
<given-names>WB</given-names>
</name>
</person-group> (<year>1974</year>) <article-title>Glutathione <italic>S</italic>-transferases. The first enzymatic step in mercapturic acid formation</article-title>. <source>The Journal of Biological Chemistry</source> <volume>249</volume>: <fpage>7130</fpage>–<lpage>7139</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera-Mendez</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Becila</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boudjellal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ouali</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Meat ageing: Reconsideration of the current concept</article-title>. <source>Trends in Food Science and Technology</source> <volume>17</volume>: <fpage>394</fpage>–<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoek</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Pastorino</surname>
<given-names>JG</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Ethanol, oxidative stress, and cytokine-induced liver cell injury</article-title>. <source>Alcohol</source> <volume>27</volume>: <fpage>63</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hrelia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fiorentini</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maraldi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Angeloni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bordoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Biagi</surname>
<given-names>PL</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>) <article-title>Doxorubicin induces early lipid peroxdation associated with changes in glucose transport in cultured cardiomyocytes</article-title>. <source>Biochimica et Biophysica Acta</source> <volume>1567</volume>: <fpage>150</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tashiro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Onodoer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ikejima</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Diosgenin induces apoptosis in hela cells via activation of caspase pathway</article-title>. <source>Acta Pharmacologica Sinica</source> <volume>25</volume>(<issue>8</issue>): <fpage>1077</fpage>–<lpage>1082</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>Tetrodotoxin poisoning</article-title>. <source>Advances in Food and Nutrition Research</source> <volume>52</volume>: <fpage>141</fpage>–<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr40-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iraimoudi</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Stamato</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Mauldin</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Biaglow</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Tuttle</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>SF</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>) <article-title>Mutation in the glucose-6-phosphate dehydrogenase gene leads to inactivation of Ku DNA end binding during oxidative stress</article-title>. <source>The Journal of Biological Chemistry</source> <volume>277</volume>(<issue>12</issue>): <fpage>9929</fpage>–<lpage>9935</lpage>.</citation>
</ref>
<ref id="bibr41-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivic</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Petrovic</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Kalman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Milosavljevic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Reljin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Reljin</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>) <article-title>AFM studies of DNA structures extracted from adriamycin treated and non-treated Ehrlich tumor cells</article-title>. <source>Journal of the American Chemical Society</source> <volume>70</volume>(<issue>6</issue>): <fpage>823</fpage>–<lpage>831</lpage>.</citation>
</ref>
<ref id="bibr42-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jemal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>) <article-title>Cancer statistics</article-title>. <source>A Cancer Journal for Clinicians</source> <volume>58</volume>(<issue>2</issue>): <fpage>71</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr43-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalaiselvi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pragasam</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chinnikrishnan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Veena</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Sundarapandiyan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Varalakshmi</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Counteracting adriamycin-induced oxidative stress by administration of <italic>N</italic>-acetyl cysteine and vitamin E</article-title>. <source>Clinical Chemistry and Laboratory Medicine</source> <volume>43</volume>(<issue>8</issue>): <fpage>834</fpage>–<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr44-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalender</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kalender</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin</article-title>. <source>Toxicology</source> <volume>209</volume>: <fpage>39</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr45-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kusano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohtsu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koya</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Kuzumaki</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>) <article-title>A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>95</volume>: <fpage>8532</fpage>–<lpage>8537</lpage>.</citation>
</ref>
<ref id="bibr46-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kawabata</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>1978</year>) <source>Food hygiene examination manual</source>. <publisher-loc>Tokyo</publisher-loc>: <publisher-name>Japan Food Hygiene Association</publisher-name>, pp.<fpage>223</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr47-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Komberg</surname><given-names>A</given-names></name>
<name><surname>Horecker</surname><given-names>B L</given-names></name><etal/>
</person-group> (<year>1955</year>) <source>Methods in Enzymology 1</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Academic Press</publisher-name>, pp.<fpage>323</fpage>.</citation>
</ref>
<ref id="bibr48-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van Dan Hoven</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rops</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wijnhoven</surname>
<given-names>T</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lensen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>) <article-title>Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin–angiotensin system</article-title>. <source>Journal of the American Society of Nephrology</source> <volume>17</volume>: <fpage>2513</fpage>–2520.</citation>
</ref>
<ref id="bibr49-0748233711434955"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KA</given-names></name><name><surname>Qian</surname><given-names>DZ</given-names></name><name><surname>Rey</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>JO</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group> (<year>2009</year>) <article-title>Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>106</volume><issue>(7)</issue>:<fpage>2353</fpage>–<lpage>2358</lpage>.</citation></ref>
<ref id="bibr50-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Longhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takemura</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yiwen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Esaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>) <article-title>Preventive effect of Erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy</article-title>. <source>Circulation</source> <volume>113</volume>: <fpage>535</fpage>–<lpage>543</lpage>.</citation>
</ref>
<ref id="bibr51-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cederbaum</surname>
<given-names>AL</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1</article-title>. <source>Toxicological Sciences</source> <volume>89</volume>(<issue>2</issue>): <fpage>515</fpage>–<lpage>523</lpage>.</citation>
</ref>
<ref id="bibr52-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minami</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1979</year>) <article-title>A simplified assay method of super oxide dismutase</article-title>. <source>Clinica Chimica Acta</source> <volume>29</volume>: <fpage>337</fpage>–<lpage>342</lpage>.</citation>
</ref>
<ref id="bibr53-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minotti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Menna</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Salvatorelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cairo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gianni</surname>
<given-names>L</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity</article-title>. <source>Pharmacological Reviews</source> <volume>56</volume>: <fpage>185</fpage>–<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr54-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Maulik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dinda</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Talwar</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Maulik</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression</article-title>. <source>BMC Pharmacology</source> <volume>10</volume>: <fpage>3</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr55-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Obrador</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Carretero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Petschen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Avino</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>) <article-title>Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumor growth in vivo</article-title>. <source>Free Radical Biology and Medicine</source> <volume>26</volume>: <fpage>410</fpage>–<lpage>418</lpage>.</citation>
</ref>
<ref id="bibr56-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Donovan</surname>
<given-names>N</given-names> </name>
<name>
<surname>Crown</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stunell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>ADK</given-names>
</name>
<name>
<surname>McDermott</surname>
<given-names>E</given-names>
</name>
<name>
<surname>O’Higgins</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>) <article-title>Caspase 3 in breast cancer</article-title>. <source>Clinical Cancer Research</source> <volume>9</volume>: <fpage>738</fpage>–<lpage>742</lpage>.</citation>
</ref>
<ref id="bibr57-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohkawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohish</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1979</year>) <article-title>Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction</article-title>. <source>Analytical Biochemistry</source> <volume>95</volume>: <fpage>351</fpage>–<lpage>358</lpage>.</citation>
</ref>
<ref id="bibr58-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Pollard</surname>
<given-names>JW</given-names>
</name>
</person-group> (<year>2009</year>) <source>Metastatic cancer and macrophages: cells thought to protect against cancer may actually promote it</source>. <comment>PhD Thesis</comment>, <publisher-loc>Yeshiva University, NY</publisher-loc>. <comment>Published online in PLOS ONE</comment>.</citation>
</ref>
<ref id="bibr59-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pompella</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Corti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paolicchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giommarelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zunino</surname>
<given-names>F</given-names>
</name>
</person-group> (<year>2007</year>) <article-title>γ-Glutamyltransferase, redox regulation and cancer drug resistance</article-title>. <source>Pharmacology</source> <volume>7</volume>: <fpage>360</fpage>–<lpage>366</lpage>.</citation>
</ref>
<ref id="bibr60-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramnath</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rekha</surname>
<given-names>PSG</given-names>
</name>
<name>
<surname>Kuttan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kuttan</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Regulation of caspase-3 and Bcl-2 expression in Dalton's lymphoma ascites cells by Abrin</article-title>. <source>Alternative Medicine</source> <volume>6</volume>(<issue>2</issue>): <fpage>223</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr61-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Le Guennec</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Besson</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastatic breast cancer cell line</article-title>. <source>British Journal of Pharmacology</source> <volume>141</volume>: <fpage>610</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr62-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Livrea1</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jirillo</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Voltage-gated sodium channel blockers as immunomodulators</article-title>. <source>Recent Patents on CNS Drug Discovery</source> <volume>1</volume>: <fpage>83</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr63-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvemini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Franze</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iervolino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Filosa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Salzano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ursini</surname>
<given-names>MV</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression</article-title>. <source>The Journal of Biological Chemistry</source> <volume>274</volume>: <fpage>2750</fpage>–<lpage>2757</lpage>.</citation>
</ref>
<ref id="bibr64-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>R</given-names> </name>
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Aronstam</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Ercal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Adam Martin</surname>
<given-names>A</given-names> </name>
<name>
<surname>Huang</surname> <given-names>YW</given-names>
</name>
</person-group> (<year>2009</year>) <article-title><italic>N</italic>-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes</article-title>. <source>BMC Pharmacology</source> <issue>(9)</issue>: <fpage>7</fpage>.</citation>
</ref>
<ref id="bibr65-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strasak</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rapp</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Brant</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Hilbe</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oberaigner</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>; <collab collab-type="author">PP Study Group</collab> (<year>2008</year>) <article-title>Association of γ-glutamyltransferase and risk of cancer incidence in men: a prospective study</article-title>. <source>Cancer Research</source> <volume>68</volume>: <fpage>3970</fpage>–<lpage>3977</lpage>.</citation>
</ref>
<ref id="bibr66-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szasz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Persijn</surname>
<given-names>JP</given-names>
</name>
</person-group> (<year>1974</year>) <article-title>Method for γ-glutamyltransferase (γGT)</article-title>. <source>Journal of Clinical Chemistry and Clinical Biochemistry</source> <volume>12</volume>: <fpage>228</fpage>.</citation>
</ref>
<ref id="bibr67-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tandon</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bardi</surname>
<given-names>GH</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Oxidative stress: a novel strategy in cancer treatment</article-title>. <source>JK Science</source> <volume>7</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr68-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timao</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Singal</surname>
<given-names>PK</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol</article-title>. <source>Circulation</source> <volume>102</volume>; <year>2105–2110</year>.</citation>
</ref>
<ref id="bibr69-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsang</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>FYF</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>TT</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>p53-R175H suppression of caspase-3 expression and doxorubicin-induced apoptosis in human osteosarcoma Saos-2 cells</article-title>. <source>Proceedings of the American Association for Cancer Research</source> <volume>46</volume>: <fpage>633</fpage>.</citation>
</ref>
<ref id="bibr70-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1967</year>) <article-title>Comparison of the growth of the Ehrlich ascites tumor in male and female mice</article-title>. <source>Cancer Research</source> <volume>27</volume>(<issue>1</issue>): <fpage>1058</fpage>–<lpage>1065</lpage>.</citation>
</ref>
<ref id="bibr71-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wajant</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>The role of TNF in cancer</article-title>. <source>Results and Problems in Cell Differentiation</source> <volume>49</volume>: <fpage>1</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr72-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Sheline</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hyrc</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>MP</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>) <article-title>Apoptotic insults impair Na<sup>+</sup>, K<sup>+</sup>-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress</article-title>. <source>Journal of Cell Science</source> <volume>116</volume>: <fpage>2099</fpage>–<lpage>2110</lpage>.</citation>
</ref>
<ref id="bibr73-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Shoemaker</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Shealy</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Bshara</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>MM</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice</article-title>. <source>Molecular Cancer</source> <volume>8</volume>: <fpage>2655</fpage>.</citation>
</ref>
<ref id="bibr74-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Whitby</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Backett</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1993</year>) <source>Lecture Notes in Clinical Biochemistry</source>. <edition>5th ed</edition>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Blackwell Scientific Publishers</publisher-name>. pp.<fpage>105</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr75-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Diwan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spinale</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>DL</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Duality of innate stress responses in cardiac injury, repair, and remodeling</article-title>. <source>Journal of Molecular and Cellular Cardiology</source> <volume>37</volume>: <fpage>801</fpage>–<lpage>811</lpage>.</citation>
</ref>
<ref id="bibr76-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Histopathological and electron microscopic changes in mice treated with puffer fish toxin</article-title>. <source>The Journal of Toxicological Sciences</source> <volume>1</volume>: <fpage>1</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr77-0748233711434955">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>DS</given-names>
</name>
</person-group> (<year>2001</year>) <source>Effects of Disease on Clinical Lab Tests</source>. <edition>4th ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>AACC Press</publisher-name>.</citation>
</ref>
<ref id="bibr78-0748233711434955">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zandwijk</surname>
<given-names>NV</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>
<italic>N</italic>-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer</article-title>. <source>Journal of Cellular Biochemistry</source> <volume>59</volume>: <fpage>24</fpage>–<lpage>32</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>